European Dx companies have the edge over US companies in Hong Kong
This article was originally published in Clinica
Executive Summary
There are few barriers, either legal or commercial, for diagnostic products entering Hong Kong, which is a duty-free port with no import tariffs on diagnostic products. It is a fiercely competitive market in which US companies are dominant (see Clinica No 1320, p 9), but they are being effectively challenged by European products, says the US Commercial Service in a July 2008 report.